AQUYRE Biosciences
PrivateLast Round
Series A
Oct 20, 2023
Total Funding Raised
$23.17M
Company Overview
AQUYRE Biosciences is a biotechnology company that develops a cellular-level optical biopsy imaging system for rapid, on-site analysis of fresh live surgical specimens, enabling quick and accurate identification of cancer and other cells.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AQUYRE Biosciences Comps
Public and private peers based on sector, stage, and business model.
AQUYRE Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 20, 2023 | ||||
| Series A Extension | Nov 15, 2021 |
Key People
Founding team and executive leadership
AQUYRE Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Series A Extension |
| SternAegis Ventures | Series A Extension |
| Aegis Capital Corp. | Series A |
| Ceros Capital Markets | Series A Extension |
| Weild Capital | Series A |
AQUYRE Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AQUYRE Biosciences's valuation, stock price, and market status.
